基于HKDC1 C端的多肽通过调节线粒体功能和抑制EBV抑制结外NK/T细胞淋巴瘤
本研究开发靶向己糖激酶结构域组分1(HKDC1)的抗肿瘤多肽,发现HKDC1在结外鼻型NK/T细胞淋巴瘤(ENKTL)细胞中高表达,敲低HKDC1可显著抑制肿瘤生长。利用转铁蛋白受体内化序列递送D型HKDC1 C端最后8个氨基酸(Tf-D-HKC8),可破坏HKDC1与VDAC1结合,导致线粒体功能障碍和活性氧过度生成,进而抑制EBV复制和P-糖蛋白表达,有效杀伤EBV阳性ENKTL细胞;局部注射该多肽在异种移植小鼠模型中显著抑制肿瘤生长和EBV复制。
要点
- HKDC1在ENKTL细胞中高表达,敲低可抑制肿瘤生长。
- Tf-D-HKC8多肽靶向HKDC1 C端,破坏其与VDAC1结合。
- 该多肽通过线粒体功能障碍和ROS过度生成抑制EBV复制和P-gp表达,杀伤EBV阳性ENKTL细胞。
核心结论
- 基于HKDC1 C端的多肽通过调节线粒体功能和抑制EBV来抑制ENKTL。
研究设计与样本
- 研究采用ENKTL细胞系和ENKTL异种移植小鼠模型,评估HKDC1敲低及Tf-D-HKC8多肽的作用。
主要发现
- HKDC1在ENKTL细胞中高表达,HKDC1敲低显著抑制ENKTL肿瘤生长。
- Tf-D-HKC8多肽抑制HKDC1与VDAC1结合,导致线粒体功能障碍和活性氧过度生成,进而抑制EBV复制和P-gp表达,有效杀伤EBV阳性ENKTL细胞。
- 在ENKTL异种移植小鼠模型中,局部注射Tf-D-HKC8多肽显著抑制肿瘤生长和EBV复制。
临床怎么用
- HKDC1 C端多肽Tf-D-HKC8可能成为治疗EBV阳性ENKTL的潜在靶向策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extranodal nasal-type natural killer/T-cell lymphoma (ENKTL) is an Epstein-Barr virus (EBV) associated lymphoma that progresses rapidly and relapses frequently. Advanced ENKTL is multidrug chemoresistant and has a poor prognosis. In this study, we aim to develop a novel hexokinase domain component 1 (HKDC1)-based antitumor target for ENKTL that is involved with the antimetabolic signaling pathway, EBV replication, and P-glycoprotein (P-gp) expression. We showed that HKDC1 is highly upregulated in ENKTL cells and HKDC1 knockdown significantly suppresses ENKTL tumor growth. In addition, HKDC1 is highly identical with four other hexokinase isoforms, with the only difference being in the last eight amino acids (aa) at the C-terminal. Further investigation showed that peptide delivery of the last eight aa of HKDC1 at the C-terminal (HKC8) with D-configuration using transferrin (Tf) receptor internalization sequence (Tf-D-HKC8) inhibits HKDC1 association with vascular endothelial growth factor 1 (VDAC1), resulting in mitochondrial dysfunction and reactive oxygen species (ROS) overgeneration and subsequently suppressing EBV replication and P-gp expression, making it very effective in killing EBV-positive ENKTL cells. Further in vivo experiments showed that local injection of Tf-D-HKC8 peptide significantly suppresses ENKTL tumor growth and EBV replication in ENKTL xenograft mouse models. We conclude that HKDC1 C-terminal-based peptides inhibit ENKTL by modulation of mitochondrial function and EBV suppression.
引用
- Chen Q, Feng J, Wu J, et al. HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression. Leukemia. 2020. PMID: 32203147. doi:10.1038/s41375-020-0801-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。